ADVISORY, March 23, 2012 (GLOBE NEWSWIRE) -- What: Amylin Pharmaceuticals, Inc. [AMLN], a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines, will visit the NASDAQ MarketSite in Times Square.
